Sunosi Dosage
Generic name: SOLRIAMFETOL 75mg
Dosage form: tablet, film coated
Drug class: Miscellaneous central nervous system agents
Medically reviewed by Drugs.com. Last updated on Jul 6, 2023.
Important Considerations Prior to Initiating Treatment
Prior to initiating treatment with SUNOSI, ensure blood pressure is adequately controlled.
General Administration Instructions
Administer SUNOSI orally upon awakening with or without food. Avoid taking SUNOSI within 9 hours of planned bedtime because of the potential to interfere with sleep if taken too late in the day.
SUNOSI 75 mg tablets are functionally scored tablets that can be split in half (37.5 mg) at the score line.
Dosage in Narcolepsy
Initiate SUNOSI at 75 mg once daily in adults with narcolepsy. The recommended dose range for SUNOSI is 75 mg to 150 mg once daily. Based on efficacy and tolerability, the dosage of SUNOSI may be doubled at intervals of at least 3 days. The maximum recommended dose is 150 mg once daily. Dosages above 150 mg daily do not confer increased effectiveness sufficient to outweigh dose-related adverse reactions.
Dosage in OSA
Initiate SUNOSI at 37.5 mg once daily in adults with OSA. The recommended dosage range for SUNOSI is 37.5 mg to 150 mg once daily. Based on efficacy and tolerability, the dosage of SUNOSI may be doubled at intervals of at least 3 days. The maximum recommended dosage is 150 mg once daily. Dosages above 150 mg daily do not confer increased effectiveness sufficient to outweigh dose-related adverse reactions.
Dosage Recommendations in Patients with Renal Impairment
Moderate renal impairment (eGFR 30-59 mL/min/1.73 m2): Initiate dosing at 37.5 mg once daily. Based on efficacy and tolerability, dose may be increased to a maximum of 75 mg once daily after at least 7 days.
Severe renal impairment (eGFR 15-29 mL/min/1.73 m2): Administer 37.5 mg once daily. The maximum recommended daily dose is 37.5 mg.
End Stage Renal Disease (eGFR <15 mL/min/1.73 m2): SUNOSI is not recommended for use in patients with ESRD.
Frequently asked questions
More about Sunosi (solriamfetol)
- Check interactions
- Compare alternatives
- Reviews (79)
- Drug images
- Side effects
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.